Moleculin Biotech Stock Forward View - Relative Strength Index
| MBRX Stock | USD 2.43 -0.06 -2.41% |
The Relative Strength Index reference data for Moleculin Biotech is derived from the equity's published trading history. The resulting forecast and deviation statistics are presented as reference data for informational context. Forecast values and accuracy statistics are presented for informational purposes. All values shown are derived from publicly available market data.
The forecast reference data presented here for Moleculin Biotech reflects Relative Strength Index model output and is intended as reference material for analytical use. Relative Strength Index Analysis Today
Moleculin Biotech has current Relative Strength Index of 30.7.| Volatility | Backtest | Information Ratio |
Moleculin Biotech Trading Date Momentum
| On March 26 2026 Moleculin Biotech was traded for 2.43 at the closing time. The top price for the day was 2.52 and the lowest listed price was 2.40 . The trading volume for the day was 109.9 K. The trading history from March 26, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.65% . |
| Compare Moleculin Biotech to competition |
Other Forecasting Options for Moleculin Biotech
Fibonacci retracement levels applied to Moleculin Stock price swings identify potential support and resistance zones. Extreme price moves in Moleculin occur more frequently than standard risk models assume. Support and resistance levels derived from Moleculin Biotech's historical data identify zones where buying or selling pressure has stalled moves. A volume spike without a corresponding price move can signal accumulation or distribution ahead of a directional breakout.Moleculin Biotech Related Equities
Investors studying Moleculin Biotech often look at related stocks within the Health Care space to gauge pricing and results. Looking at Moleculin Biotech's pricing multiples next to these peers shows if the stock trades at a premium or discount. When Moleculin Biotech breaks from its peer group on a key metric, it often signals a firm-level change worth exploring. The data below allows side-by-side review across the most common financial metrics.
| Risk & Return | Correlation |
Moleculin Biotech Market Strength Events
Tracking market strength indicators for Moleculin Biotech provides context for understanding stock momentum dynamics. Tracking these indicators helps identify periods where trading Moleculin Biotech is likely to be most rewarding. These tools are essential for timing trades in Moleculin Biotech with a quantitative framework. Market strength indicators for Moleculin Biotech are most useful when viewed as part of a broader analytical framework.
Moleculin Biotech Risk Indicators
Properly assessing Moleculin Biotech's risk indicators is a prerequisite for building reliable price forecasts. This analysis provides context for determining the appropriate level of risk to accept when holding Moleculin Biotech's. Analyzing Moleculin Biotech's risk indicators provides a critical input for investment risk management. By quantifying the risk in Moleculin Biotech's investment, investors can make more informed decisions about hedging strategies.
| Mean Deviation | 4.31 | |||
| Standard Deviation | 7.23 | |||
| Variance | 52.25 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Moleculin Biotech
Story coverage around Moleculin Biotech often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Contributor Headline
Latest Perspective From Macroaxis
Moleculin Biotech Short Properties
Reviewing short-oriented indicators for Moleculin Biotech is useful because long and short participants often create very different signals for timing and volatility. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
| Common Stock Shares Outstanding | 11.8 M | |
| Cash And Short Term Investments | 8.9 M |